Praxis Precision Medicines, Inc. PRAX

Set alert

Price alert · PRAX

All alert types
282.02 USD +8.02 +2.93%

As of Nov 3, 9:52 AM ET

Bid
280.88 × 1
Ask
282.93 × 1
276.00 Day range 286.01
164.09 52-week range 386.33
YTD
-4.32%
1 year
+54.96%
Open
279.92
Prev close
273.99
Mkt cap
7.90B
Vol
12.01K
Avg vol
460.19K
EPS
-12.95
P/E
0.00
Div yield
0.00%
More statistics
Low
276.00
High
286.01
Forward P/E
-28.83
Beta
2.84
Short ratio
7.11
Inst. own
123.51%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
301.29
200-d avg
314.83
1y target
650.00

3M chart

Chart tools
Interval

Events in this range
  • Aug 6, 2026Earnings: -2.87; estimate -3.67; surprise 21.8%
  • Sep 24, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 6, 2026Rating: BTIG · Buy → Buy
  • Oct 6, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 15, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 15, 2026Rating: UBS · — → Buy
  • Oct 16, 2026Rating: JP Morgan · — → Overweight
Signals (11)
NameDateAgo
SMA: BullishOct 28, 20266 days ago
MACD: Buy SignalOct 20, 20262 weeks ago
RSI: OversoldOct 8, 20263 weeks ago
RSI: OversoldSep 23, 20261 month ago
SMA: BearishSep 10, 20261 month ago
SMA: BearishSep 9, 20261 month ago
MACD: Sell SignalAug 25, 20262 months ago
MACD: Buy SignalAug 6, 20262 months ago
SMA: BullishAug 5, 20263 months ago
SMA: BullishAug 4, 20263 months ago
SMA: BearishAug 3, 20263 months ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 650.00 +130.5% upside
Target (low)
188.00
Target (mean)
650.00
Target (high)
1,201.00
Ratings (0m) 21 19 buy · 1 hold · 1 sell
  • Strong buy4
  • Buy15
  • Hold1
  • Sell1
  • Strong sell0

Recommendation trend

  • This month 21
  • 1 month ago 19
  • 2 months ago 19

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

PRAX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-3.63-5.60 – -2.74-3.36-8.2%00.0%19
Next quarter-4.24-7.96 – -3.26-3.50-21.2%830.71K0.0%19
Current year-14.02-19.83 – -12.07-13.48-4.0%830.71K0.0%19
Next year-9.50-17.88 – 5.21-14.02+32.3%345.10M+41442.6%18

Upgrades and downgrades

The latest rating changes

PRAX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 16, 2026JP MorganInitiated—Overweight
Oct 15, 2026UBSInitiated—Buy
Oct 15, 2026HC Wainwright & Co.ReiteratedBuyBuy
Oct 6, 2026HC Wainwright & Co.ReiteratedBuyBuy
Oct 6, 2026BTIGMaintainedBuyBuy
Sep 24, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 24, 2026NeedhamReiteratedBuyBuy
Aug 21, 2026Goldman SachsMaintainedBuyBuy
Aug 7, 2026RBC CapitalMaintainedOutperformOutperform
Aug 7, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Aug 6, 2026NeedhamMaintainedBuyBuy
Jul 29, 2026BTIGReiteratedBuyBuy
Jul 13, 2026Goldman SachsInitiated—Buy
Jun 29, 2026NeedhamMaintainedBuyBuy
Jun 18, 2026RBC CapitalInitiated—Outperform
Jun 2, 2026OppenheimerMaintainedOutperformOutperform
Jun 2, 2026Truist SecuritiesMaintainedBuyBuy
Jun 2, 2026Deutsche BankMaintainedBuyBuy
Jun 2, 2026WedbushMaintainedUnderperformUnderperform
Jun 2, 2026BairdMaintainedOutperformOutperform
Jun 2, 2026HC Wainwright & Co.MaintainedBuyBuy
Jun 2, 2026BTIGMaintainedBuyBuy
May 26, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 20, 2026BTIGReiteratedBuyBuy
May 13, 2026Truist SecuritiesMaintainedBuyBuy
May 8, 2026WedbushMaintainedUnderperformUnderperform
May 8, 2026BTIGReiteratedBuyBuy
Apr 14, 2026NeedhamReiteratedBuyBuy
Apr 7, 2026HC Wainwright & Co.ReiteratedBuyBuy
Apr 6, 2026BTIGReiteratedBuyBuy